Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.
Christina Maria FliesKarlijn H van LeukenMarlies Ten VoordeJoost J C VerhoeffFilip Yves Francine De VosTatjana SeutePierre A RobeTheodoor D WitkampJeroen HendrikseJan Willem DankbaarTom Jan SnijdersPublished in: Neurology (2022)
This study provides Class II evidence that in patients with irradiated HGGs, radiation dose, longer TTP, marginal enhancement, soap bubble enhancement, and isointense ADC signal distinguish progressive disease from TIE.